Click to Share
 

Drug Discovery Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12559894
By MoBiTec GmbH
TargetMol supplies over 3000 compounds used in the study of cell signaling pathways and drug discovery. TargetMol provides more than 32 types of compound libraries, available for cell induction, signaling pathway, and high-throughput screening (HTS).
12550930
By Peptides International
With all the news and concern about the Zika virus pandemic currently developing, Peptides International is pleased to announce that the company has added five new Zika virus proteins to its recombinant protein catalog offerings.
12549599
By MoBiTec GmbH
Montana Molecular develops genetically encoded fluorescent biosensors and probes for cell-based assays and live cell imaging. MT Molecular products are used for drug discovery and to observe and measure cell signaling processes.
By BPS Bioscience
BPS Bioscience, Inc. (“BPS”) announces the addition of a one-of-a-kind assay kit designed to screen for inhibitors of IL-17A interaction with IL-17RA.
12529014
By Admescope
Regulatory compliant package to investigate transporter-mediated drug-drug interactions
By kdm communications
Tecan has launched the Spark® 20M multimode microplate reader*, offering tailor-made solutions to suit virtually any drug discovery or advanced life science research application.
12516712
By MoBiTec GmbH
Manufactured by Mirus Bio LLC, USA, MoBiTec now offers a transient transfection platform that produces high protein titers with robust cell growth in relevant CHO cells.
12427481
By MoBiTec GmbH
MoBiTec, Germany, heartily invite to a free webinar on Transcreener® HTS assays hosted by BBL, USA: Learn how these assays can be used for direct detection of diverse human and microbial glycosyltransferases by measuring inhibitor dose responses.
12389210
By SMi Group
Advances and Progress in Drug Design, 16th and 17th February, London UK
12377577
By SMi Group Ltd
Advances and Progress in Drug Design, 16th & 17th February 2015, Marriott Regents Park Hotel, London UK
12376192
By MoBiTec GmbH
In 2009, Phosphodiesterase 4D (PDE4D) was identified as a novel proliferation-promoting factor in prostate cancer. Now, the effects of two selective PDE4D inhibitors, NVP-ABE171 and cilomilast, as anti-prostate cancer therapies were examined.
12374189
By SMi Group Ltd
7th annual Advances in Cell Based Assays conference takes place in London, on the 11th - 12th November 2014.
By Cambridge Healthtech Institute
Drug Discovery Teams to Unite for 3 Days of Learning & Collaboration - Free Passes Provide Access to Keynote Presentations by Chas Bountra, Martin Tolar, Andrew Hopkins and an Expansive Exhibit Hall
By Cambridge Healthtech Institute
Novartis, AstraZeneca and Merck to lead an assembly of drug discovery teams in discussing maximizing information in early drug discovery with phenotypic screening
By InvitroCue Pte Ltd
InvitroCue and HD Biosciences Enter Collaboration Agreement for the Validation of Image Analysis Tools for Preclinical Drug Discovery
By Crown Bioscience
HuTrialTM demonstrates commitment to furthering preclinical understanding in order to improve personal care and increase patient recovery rates
By BPS Bioscience, Inc
BPS Bioscience, Inc. (“BPS”) has developed several new assay kits (BTLA:HVEM, CD28:B7-1, and CTLA4:B7-1) and related proteins to advance immunotherapy research.
By Virtue Insight
5th Annual Clinical Trials Summit 2014 "A critical guide for successfully conducting clinical trials” 10th & 11th June 2014, Kohinoor Continental Hotel, Mumbai, India
By Peptides International
Nearly Five Thousand Unique Products Will Be Available Worldwide
By BPS Bioscience, Inc.
BPS Bioscience, Inc. introduces unique EZH2 mutants and 2 new assay kits for screening EZH2 inhibitors

All Press Releases

12559894
By MoBiTec GmbH
TargetMol supplies over 3000 compounds used in the study of cell signaling pathways and drug discovery. TargetMol provides more than 32 types of compound libraries, available for cell induction, signaling pathway, and high-throughput screening (HTS).
By Markets and Markets
Dr. Tobias A. Knoch, Group Leader, Biophysical Genomics - Erasmus MC has joined the speaker panel for the 2nd Annual Epigenetics Discovery Congress.
By Markets and Markets
Dr. James Gulley, an internationally recognized expert in cancer immunotherapy has joined the speaker panel for the Cancer Immunotherapy Congress organized by Markets and Markets Conferences.
12550930
By Peptides International
With all the news and concern about the Zika virus pandemic currently developing, Peptides International is pleased to announce that the company has added five new Zika virus proteins to its recombinant protein catalog offerings.
12549599
By MoBiTec GmbH
Montana Molecular develops genetically encoded fluorescent biosensors and probes for cell-based assays and live cell imaging. MT Molecular products are used for drug discovery and to observe and measure cell signaling processes.
By BPS Bioscience
BPS Bioscience, Inc. (“BPS”) announces the addition of a one-of-a-kind assay kit designed to screen for inhibitors of IL-17A interaction with IL-17RA.
By SMi Group
SMi reports (17.02.2016, London UK) ADCETRIS Global Medical Lead joins expert speaker panel at the 5th annual ADC Summit in London
12529014
By Admescope
Regulatory compliant package to investigate transporter-mediated drug-drug interactions
By kdm communications
Tecan has launched the Spark® 20M multimode microplate reader*, offering tailor-made solutions to suit virtually any drug discovery or advanced life science research application.
12516712
By MoBiTec GmbH
Manufactured by Mirus Bio LLC, USA, MoBiTec now offers a transient transfection platform that produces high protein titers with robust cell growth in relevant CHO cells.
By StemTek Therapeutics
Targeted compound library to be screened for designer molecules that attack cancer stem cells for novel drug therapy use
By kdm Communications ltd
Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has been acquired by specialist healthcare investor GHO Capital, with financial details of the transaction remaining undisclosed.
By BPS Bioscience, Inc.
Identify Histone Demethylase Inhibitors against the largest panel available with BPS Bioscience
By Peptides International
Hepcidin-Murine Compete™ ELISA Kit is available now and other novel hepcidin ELISA kits are in development
By Peptides International
Peptides International Inc., a privately held biotech company, is proud to report that Dalazatide (formerly known as ShK-186), a venom-derived peptide from a sea anemone similar to Stichodactyla Toxin (ShK) (Amide) licensed to the biotechnology company...
By kdm communications
The popular HP D300 Digital Dispenser – available from Tecan – now allows customers to titrate low volumes of biomolecules in aqueous solutions, offering greater flexibility for drug discovery workflows.
By SMi Group Ltd
SMi’s BioBanking conference will be taking place on the 22 - 23 June 2015 at the Holiday Inn Regents Park Hotel in London, UK.
By MoBiTec GmbH
MoBiTec, Germany, heartily invite to a free BBL webinar on: Transcreener HTS assays enable the screening and profiling of a wide variety of enzymes. These assays can also be run in kinetic mode, allowing inquiry into the enzymology of targets.
By Curtis & Coulter, LLC
Dr. Stephen r. Byrn, phd, professor of medicinal chemistry at purdue university, to speak at 2nd controlled & modified drug release and drug delivery strategies
12427481
By MoBiTec GmbH
MoBiTec, Germany, heartily invite to a free webinar on Transcreener® HTS assays hosted by BBL, USA: Learn how these assays can be used for direct detection of diverse human and microbial glycosyltransferases by measuring inhibitor dose responses.
By MoBiTec GmbH
Like the existing UDP2 FP assay, the TR-FRET assay provides sensitive detection of glycosyltransferases and other UDP-producing enzymes. The new Transcreener UDP2 TR-FRET Assay will better serve a growing need for robust, HTS-proven assays.
By Neurolixis, Inc.
Strategic Collaboration Focused On Generation of Novel CNS Therapeutics
12389210
By SMi Group
Advances and Progress in Drug Design, 16th and 17th February, London UK
By MoBiTec GmbH
An Application Note is published to serve as a guide for using BellBrook Labs' Transcreener® GDP Assay to detect the activity of guanine nucleotide exchange factors (GEFs) based on their stimulation of steady state GTPase activity.
12377577
By SMi Group Ltd
Advances and Progress in Drug Design, 16th & 17th February 2015, Marriott Regents Park Hotel, London UK
12376192
By MoBiTec GmbH
In 2009, Phosphodiesterase 4D (PDE4D) was identified as a novel proliferation-promoting factor in prostate cancer. Now, the effects of two selective PDE4D inhibitors, NVP-ABE171 and cilomilast, as anti-prostate cancer therapies were examined.
12374189
By SMi Group Ltd
7th annual Advances in Cell Based Assays conference takes place in London, on the 11th - 12th November 2014.
By Cambridge Healthtech Institute
Drug Discovery Teams to Unite for 3 Days of Learning & Collaboration - Free Passes Provide Access to Keynote Presentations by Chas Bountra, Martin Tolar, Andrew Hopkins and an Expansive Exhibit Hall
By Cambridge Healthtech Institute
Novartis, AstraZeneca and Merck to lead an assembly of drug discovery teams in discussing maximizing information in early drug discovery with phenotypic screening
By SMi Group Ltd
SMi Group reports (2014.08.22, London): In preparation for the 5th annual Biosimilars and Biobetters Conference, SMi Group has conducted a series of interviews with leading industry experts

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share